You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Aromatase inhibitors for subfertile women with polycystic ovary syndrome
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2014
|
| DOI | 10.1002/14651858.cd010287.pub2 |
| Pubmed ID | |
| Authors |
Sebastian Franik, Jan AM Kremer, Willianne LDM Nelen, Cindy Farquhar |
| Abstract |
Polycystic ovary syndrome (PCOS) is the most common cause of infrequent periods (oligomenorrhoea) and absence of periods (amenorrhoea). It affects about 4% to 8% of women worldwide and often leads to anovulatory subfertility. Aromatase inhibitors (AIs) are a novel class of drugs that were introduced for ovulation induction in 2001. Over the last ten years clinical trials have reached differing conclusions as to whether the AI letrozole is at least as effective as the first-line treatment clomiphene citrate (CC). |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 43% |
| United States | 2 | 29% |
| Netherlands | 1 | 14% |
| Unknown | 1 | 14% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 57% |
| Practitioners (doctors, other healthcare professionals) | 3 | 43% |
Mendeley readers
The data shown below were compiled from readership statistics for 184 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 1 | <1% |
| Brazil | 1 | <1% |
| United Kingdom | 1 | <1% |
| Ukraine | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 179 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 32 | 17% |
| Student > Master | 31 | 17% |
| Student > Bachelor | 20 | 11% |
| Student > Ph. D. Student | 17 | 9% |
| Student > Postgraduate | 11 | 6% |
| Other | 37 | 20% |
| Unknown | 36 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 86 | 47% |
| Nursing and Health Professions | 12 | 7% |
| Biochemistry, Genetics and Molecular Biology | 10 | 5% |
| Psychology | 7 | 4% |
| Agricultural and Biological Sciences | 6 | 3% |
| Other | 24 | 13% |
| Unknown | 39 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 August 2022.
All research outputs
#1,625,057
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#3,464
of 11,499 outputs
Outputs of similar age
#16,080
of 237,723 outputs
Outputs of similar age from Cochrane database of systematic reviews
#73
of 228 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 237,723 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 228 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.